UTICA — ConMed Corp. (NASDAQ: CNMD), a Utica–based medical-device maker, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents per share for the third quarter. The dividend will be payable on Oct. 7 to all shareholders of record as of Sept. 13. At the company’s current stock price, […]
UTICA — ConMed Corp. (NASDAQ: CNMD), a Utica–based medical-device maker, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents per share for the third quarter.
The dividend will be payable on Oct. 7 to all shareholders of record as of Sept. 13.
At the company’s current stock price, the dividend yields about 0.85 percent on an annual basis.
ConMed says it’s a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The firm’s products are used by surgeons and physicians in specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology.
The company expects to report full-year 2019 sales in the range of about $951 million to $958 million. ConMed generated net sales of nearly $457 million in the first six months of this year, up more than 10 percent from almost $415 million in the first half of 2018.
